We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Gentex Corp. | TG:GTX | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.40 | -4.64% | 28.80 | 28.60 | 28.80 | 30.00 | 28.00 | 30.00 | 140 | 22:50:16 |
Hot Features
Premium
RNS Number:3911K
Genetix Group PLC
25 April 2003
Statement following Annual General Meeting
New Milton, UK, 25 April 2003 -- Genetix Group plc ("Genetix") announces that at
its Annual General Meeting ("AGM") held today, all resolutions were duly passed.
Enquiries:
Genetix Group plc Tel: 01425 624600
Mark Reid, Chief Executive
Gary Corsi, Finance Director
Financial Dynamics Tel: 020 7831 3113
Jonathan Birt/Francetta Carr
Notes to Editors
About Genetix Group plc
Genetix Group plc is a leading developer of automated systems for the
understanding of systems biology. Genetix made a significant contribution to
the Human Genome Project by supplying high-throughput equipment to seven of the
leading eight laboratories in the consortia. Genetix, through its R&D expertise
and scientific resource, is committed to the continual development of innovative
solutions to accelerate the rate of global scientific discovery. Genetix is
quoted on the London Stock Exchange and is based in New Milton, Hampshire, UK.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMIAMTTMMMTBMJ
1 Year Gentex Chart |
1 Month Gentex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
